Share
About Event
Christine Horejs
Christine started at Springer Nature in 2017 as an editor for Nature Reviews Materials, where she handled the topics of biomaterials, nanomedicine, and bioengineering. From July 2019, she moved to be a senior editor at Nature Nanotechnology, where she was primarily responsible for the areas of nanomedicine and nanobiotechnology. In January 2021, she became chief editor of Nature Reviews Materials, and since January 2022, she has been chief editor of Nature Reviews Bioengineering. Christine has an MSci and PhD in nanobiotechnology from the University of Natural Resources and Life Sciences, Vienna, Austria. She did her postdoc in the lab of Molly Stevens at Imperial College London, UK, investigating the extracellular matrix and cell–material interactions, and she conducted research at the Karolinska Institute, Sweden, where she studied anti-fibrotic biomaterials in vivo. Christine is based in Berlin, Germany.
Journal Information
Nature Reviews Bioengineering is an online-only journal publishing authoritative, accessible, and agenda-setting Reviews, Perspectives, and Comments covering the full breadth of bioengineering, focusing on application, translation, and technology, that is, leveraging biological knowledge to engineer solutions for real-world applications.
Nature Reviews Bioengineering aims to bring together scientists and engineers interested in the design of materials, tools, methods, technologies or devices to mimic, modify or control biology, to understand biological mechanisms, combat disease or address environmental issues; clinicians leveraging research outputs in bioengineering to improve human health; and readers interested in product development, technology transfer, and translation.
The journal also aims to highlight bioengineering approaches in the United Nations Sustainable Development Goals (SDGs) framework, in particular, good health and well-being, zero hunger, gender equality, reduced inequalities, responsible consumption and production, and climate action. In addition, we seek to amplify diverse voices, provide a platform for discussion, debate and solution, and publish pieces that discuss commercial, ethical, legal and societal aspects of bioengineering research, and the translation of bioengineering advances in low-resource settings.
We are interested in all areas of bioengineering, including the work of scientists in academia and industry.
Journal Impact Factor: 42.7 (2025) Web link: https://www.nature.com/natrevbioeng/
Programme
- 09:00 – Opening talk: doc. Ing. Ladislav Janíček, Ph.D., MBA, LL.M., BUT rector
- 09:25 – Morning lecture: Dr Christine-Maria Horejs, Chief Editor, Nature Reviews Bioengineering, Nature Portfolio
- 10:25–10:45 – Q&A and interaction with attendees
REGISTRATION IS NECESSARY! Please register below.
